Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
GUCY2D is a type I transmembrane guanylate cyclase encoded by the GUCY2D gene. This enzyme localizes predominantly to photoreceptor outer-segment membranes, and contains an extracellular domain, a single transmembrane segment, and intracellular kinase homology and catalytic cyclase domains. Proper polypeptide folding and membrane localization are prerequisites for catalytic activity and photoreceptor function. GUCY2D expression appears largely restricted to retinal photoreceptor populations, and polypeptide abundance varies under distinct light adaption cellular contexts. Posttranslational modifications applied to GUCY2D itself could tune its catalytic activity and may adjust the extent of cyclic nucleotide synthesis within photoreceptor compartments. Distinct cellular milieus tend to reshape the functional pool of GUCY2D molecules, as surrounding light dependent signalling environment can influence enzyme activation toward catalytic output. Variation of polypeptide abundance does not always correspond to equivalent signalling output, since intracellular regulatory factor availability can place additional constraints on enzyme driven molecular events. GUCY2D (RetGC1) converts GTP to cGMP and is regulated intracellularly by the Ca²⁺-binding proteins GCAP1 and GCAP2, rather than by an established extracellular physiological ligand.
GUCY2D mediated cyclic nucleotide synthesis modifies photoreceptor signalling status and might contribute to reshaping of phototransduction molecular assemblies. Variation in GUCY2D expression level alters the total pool of accessible enzyme molecules within photoreceptor environments. Residue alteration within catalytic cyclase domain can impair cyclic nucleotide synthesis capability. Sequence variation within regulatory homology domain could disturb enzyme activation behaviours without abolishing full length polypeptide folding. Shifts in photoreceptor GUCY2D abundance may reshape the range of cyclic nucleotide output and modulate downstream molecular events linked to phototransduction cascade. Different intracellular regulatory factors may display uneven sensitivity toward GUCY2D mediated activation, which is proposed to generate graded biological responses inside photoreceptor cellular systems. Altered enzyme availability might indirectly reshape the composition of phototransduction associated molecular complexes by changing cyclic nucleotide status of selected partners. Such indirect effects do not rely on stable physical interaction between GUCY2D and every downstream effector molecule, and can expand the scope of molecular events influenced by this retinal guanylate cyclase within complex photoreceptor contexts.
Fig. 1 GUCY2D is a type-I single-pass transmembrane guanylate cyclase expressed in retinal photoreceptors, comprising an N-terminal signal sequence, extracellular domain, transmembrane helix, intracellular regulatory segments, and C-terminal guanylyl cyclase catalytic domain for cGMP synthesis.1
The biological functions of GUCY2D are focused on cyclic nucleotide synthesis, photoreceptor outer-segment membrane anchoring and modulation of photoreceptor signalling status:
Creative Biolabs offers purified GUCY2D protein samples via standardized preparation workflows, including full length GUCY2D constructs and isolated individual domain variants. Isolated domain fragments cannot recapitulate complete multi segment coordinated behaviours observed for full length polypeptide, while full length constructs may be suited for retinal guanylate cyclase and catalytic activity associated research. All samples receive routine quality screening. Assays that depend on intact membrane topology or full-complex function require appropriately constituted systems; isolated domains or fragments may support other defined assays according to the research objective. All sample batches follow unified processing standards to maintain consistent structural features for comparative laboratory analysis across separate test groups.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable GUCY2D expression cell models with varied expression levels, applicable to retinal guanylate cyclase characteristic observation and catalytic output related research. Sample evaluation includes sustained target expression detection and preliminary enzymatic activity associated observation, which can support comparative analysis of cyclase associated behaviours under different expression statuses. These cell systems can be matched with diverse laboratory analysis schemes to observe changes of catalytic output efficiency under different target expression abundances.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Antibody reagents targeting GUCY2D are generated via mature protein preparation workflows, compatible with multiple routine laboratory detection methods for cellular localization profiling and molecular complex identification, to support systematic analysis of GUCY2D distribution and phototransduction associated molecular complexes across diverse laboratory research setups. The antibody series can cooperate with other common laboratory detection reagents to complete multi dimensional observation of target distribution inside tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for GUCY2D research:
GUCY2D may function as retinal transmembrane guanylate cyclase and participate in cyclic nucleotide synthesis, plasma membrane anchoring and modulation of photoreceptor signalling status.
GUCY2D expression status may influence available enzyme pool for cyclic nucleotide output, serving as a regulatory mediator of phototransduction related biological processes.
No, all GUCY2D related products and services are strictly for research use only, not intended for clinical related operations. All material designs and functional tests are only optimized for basic laboratory research scenarios, without matching clinical application standards.
Offerings include full length GUCY2D protein, target specific recombinant antibodies and adjustable expression cell research models, supporting guanylate cyclase catalytic activity research.
These reagents are suited for research focused on GUCY2D driven molecular events, including catalytic domain function, cyclic nucleotide synthesis and photoreceptor phototransduction related mechanistic studies under laboratory research only settings.